Acute Lymphoid Leukemia clinical trials

Explore recruiting acute lymphoid leukemia clinical trials.

Recruiting acute lymphoid leukemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Lymphoid Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B1) conjugated with the co-stimulatory regions 4-1BB and CD3z (ARI-0001 cells) in patients with CD19+ acute lymphoid leukemia resistant or refractory to therapy

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults with Acute Lymphoblastic Leukemia

Belgium, France

Phase II and Phase III (Integrated) EU CTIS Study details

Acute Lymphoid Leukemia trials by city

Acute Lymphoid Leukemia clinical trials

Recruiting acute lymphoid leukemia studies right now

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Orphan Indications for CD19 Redirected Autologous T Cells

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation

Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy

Also recruiting in Europe

GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults with Acute Lymphoblastic Leukemia

Acute Lymphoid Leukemia trials by city

Other conditions